Implantable delivery device for administering pharmacological agents to an internal portion of a body

• US 20060258994A1
• Filed: 05/01/2006
• Published: 11/16/2006
• Est. Priority Date: 05/12/2005
• Status: Abandoned Application

• Current Assignee: Robert L. Avery
• Original Assignee: Robert L. Avery
• Inventors: Avery, Robert L.
• Application Number:
  US11/415,054
• Publication Number:
  US 20060258994A1
• Time in Patent Office: Days
• US Class Current: 604/294
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts

Abstract

An implantable refillable device to deliver pharmacologic agents through a sclera to an internal portion of an eye is shown. The device comprises a hollow reservoir and a delivery tube. The delivery tube has a proximal end and a distal end. The proximal end communicates with the hollow reservoir and the distal end terminates in a dispensing outlet. The delivery tube is configured in a selected shape to extend from the hollow reservoir anterior in an eye to a posterior segment posterior in an eye adjoining a sclera. The second end is configured to position the dispensing outlet in contact with or contiguous the sclera and is located posteriorly in an eye and proximate to an internal portion of an eye to be treated with a pharmacologic agent. An implantable device to deliver pharmacologic agents through an outer surface tissue of an organ is also shown.

Claims

1. An implantable refillable device to deliver pharmacologic agents through a sclera to an internal portion of an eye comprising

a hollow reservoir;

a delivery tube having a first end and a second end, said first end communicating with the hollow reservoir and said second end terminating in a dispensing outlet and wherein said delivery tube is configured in a selected shape to extend from the hollow reservoir anterior in an eye to a posterior segment in an eye adjoining a sclera;

said second end being configured to position said dispensing outlet in contact with or contiguous a sclera and being located posteriorly in an eye and proximate to an internal portion of an eye to be treated with a pharmacologic agent.

2. The implantable refillable device of claim 1 wherein said dispensing outlet is in the form of an unobstructed opening to enable a pharmacologic agent to pass therethrough.

3. The implantable refillable device of claim 1 further comprising

a permeable membrane located in said dispensing outlet and wherein said permeable membrane is selected to have a porosity to pass a pharmacologic agent therethrough and a structural integrity to resist tissue from the outer surface portion of the sclera migrating in to and occluding the dispensing outlet.

4. The implantable refillable device of claim 1 wherein said delivery tube has a selected distance between said first end and said second end to position said dispensing outlet on the sclera and curved inferior of the inferior oblique muscle to position said dispensing outlet to overlie the macula region of the sclera to enable a pharmacologic agent to pass through the sclera and into the macula.

5. The implantable refillable device of claim 1 wherein said delivery tube has a selected distance between said first end and said second end to position said dispensing outlet having a selected surface area in contact with or contiguous sclera on a posterior segment of the eye, beneath two rectus muscles and positioned to overlie the macula region of the sclera enabling the dispensing outlet to administer a pharmacologic agent over a large surface area of the sclera overlaying the macula region of the sclera to enable a pharmacologic agent to pass through the sclera and into the macula.

6. The implantable refillable device of claim 1 wherein said delivery tube has a selected distance between said first end and said second end to position said dispensing outlet on the sclera adjacent to an optic nerve of an eye to enable a pharmacologic agent to pass through the sclera and into the optic nerve.

7. The implantable refillable device of claim 1 wherein said delivery tube has a selected distance between said first end and said second end to position said dispensing outlet on the sclera located proximate the optic nerve of an eye to enable a pharmacologic agent to pass through the sclera into the optic nerve.

8. The implantable refillable device of claim 1 wherein said said dispensing outlet is configured to be placed circumferentially around a portion of the sclera of an optic nerve of an eye to enable a pharmacologic agent to pass through the sclera into the optic nerve.

9. The implantable refillable device of claim 1 wherein said delivery tube has a selected distance between said first end and said second end to position said dispensing outlet on the sclera proximate the optic nerve of an eye to enable a pharmacologic agent to pass therethrough and into the sclera surrounding the optic nerve to enable a pharmacologic agent to pass through the sclera and into the optic nerve.

10. The implantable refillable device of claim 9 wherein said dispensing outlet is configured to be placed circumferentially around a portion of the sclera surrounding an optic nerve of an eye to enable a pharmacologic agent to pass through the sclera into the optic nerve.

11. The implantable refillable device of claim 1 wherein said hollow reservoir has an internal cavity and a self-sealing needle insertion section to enable a needle to be passed through said needle insertion section and into the internal cavity to enable filling of the internal cavity with a pharmacologic agent to be dispensed in an eye.

12. The implantable refillable device of claim 1 wherein the implantable refillable device is configured to have one or more needles inserted sequentially into and removed from the self-sealing needle insertion section for administrating repeated juxtasclera injections into the posterior segment of the eye to treat an internal portion of an eye.

13. The implantable refillable device of claim 1 wherein the implantable refillable device is treated or impregnated with pharmacologic agents to minimize fibrosis and scaring around the device.

14. The implantable refillable device of claim 1 wherein said hollow reservoir has an internal cavity and a self-sealing needle insertion section to enable a needle to be passed through said needle insertion section and into the internal cavity containing a pharmacologic agent to be dispensed in an eye to enable withdrawing of a pharmacologic agent from the internal cavity.

15. The implantable refillable device of claim 1 wherein said hollow reservoir has an internal cavity and a self-sealing needle insertion section, said needle insertion section being configured to retain a pharmacologic agent located with the internal cavity to prevent refluxing of a pharmacologic agent over the eye and being positioned relative to the anterior portion of an eye to enable a needle to be passed through said needle insertion section and into the internal cavity to enable filling of the internal cavity with a pharmacologic agent to be used for treating an eye.

16. The implantable refillable device of claim 1 wherein said hollow reservoir has an internal cavity, a needle insertion section and an impermeable shield spaced distally from the needle insertion section to prevent further penetration of a needle of a syringe after entering the needle insertion section to inhibit a syringe needle from passing therethrough and into an eye.

17. The implantable refillable device of claim 1 wherein said hollow reservoir has an internal cavity, a needle insertion section and an impermeable shield spaced distally from the needle insertion section, said needle insertion section being configured to retain pharmacologic agent located with the internal cavity from refluxing over the eye and being positioned relative to the anterior portion of an eye to enable a syringe needle to be passed through said needle insertion section and into the internal cavity to enable filling of the internal cavity and wherein said impermeable shield prevents a syringe needle from passing therethrough into an eye.

18. The implantable refillable implant of claim 1 wherein eyelet for suturing the device to a sclera are formed in an anterior section of the device.

19. The implantable refillable implant of claim 1 wherein a medical adhesive is applied to that portion of the device to be placed in contact with or contiguous a sclera.

20. An implantable refillable device to deliver drugs through a posterior outer surface of an eye to an internal portion of an eye comprising

a hollow reservoir, said hollow reservoir having an internal cavity and a needle insertion section, said needle insertion section being configured to retain a drug located within the internal cavity from refluxing over the eye and being positioned relative to the anterior portion of an eye to enable a syringe needle to be passed through said needle insertion section and into the internal cavity to enable filling of the internal cavity with a drug and withdrawing of a drug from the internal cavity;

and

a delivery tube having a proximal end and a distal end, said proximal end communicating with the hollow reservoir and said distal end terminating in a drug dispensing outlet wherein said delivery tube is configured in a generally curved shape to extend from the hollow reservoir anterior in an eye to a posterior segment posterior in an eye adjoining a sclera;

said second end being configured to position said drug dispensing outlet in contact with or contiguous a posterior outer surface of an eye.

21. The implantable refillable device of claim 20 wherein said hollow reservoir further comprises

an impermeable shield spaced distally from the needle insertion section to prevent further penetration of a needle of a syringe after entering the needle insertion section to inhibit a syringe needle from passing therethrough and into an eye.

22. The implantable refillable device of claim 20 wherein said dispensing outlet is positioned in contact with or contiguous the sclera of an eye above the macula.

23. The implantable refillable device of claim 20 wherein said dispensing outlet is positioned in contact with or contiguous the sclera of an eye above the optic nerve.

25. The implantable refillable device of claim 20 wherein said dispensing outlet is configured to be placed circumferentially around a portion of the outer surface of an optic nerve of an eye.

26. An implantable refillable device to deliver a pharmacologic agent directly through an outer surface of an eye to an internal portion of an eye to be treated comprising

a hollow reservoir;

a delivery tube having a first end and a second end, said first end communicating with the hollow reservoir and said second end terminating in a pharmacologic agent dispensing outlet wherein said delivery tube is configured in a shape to extend from the hollow reservoir anterior in an eye to a posterior segment posterior in an eye and adjoining a sclera;

said second end being configured to be position said a pharmacologic agent-dispensing outlet in contact with or contiguous a sclera of an eye locate above an internal portion of an eye to be treated with a pharmacologic agent.

27. An implantable refillable device of claim 26 wherein said dispensing outlet is positioned in contact with or contiguous a sclera of an eye proximate the macula.

28. An implantable refillable device of claim 26 wherein said dispensing outlet is positioned in contact with or contiguous a sclera of an eye proximate the optic nerve.

29. An implantable refillable device of claim 26 wherein said dispensing outlet is positioned in contact with or contiguous a sclera surrounding the optic nerve.

30. A method for treating an eye comprising the steps of

forming an implantable refillable device to deliver a pharmacologic agent to an internal portion of an eye having a hollow reservoir and a delivery tube having a first end and a second end wherein said first end communicates with the hollow reservoir, wherein said delivery tube is configured in a shape to extend from the hollow reservoir anterior in an eye to a posterior segment posterior in an eye adjoining a sclera and wherein said second end terminates in a dispensing outlet to be position in contact with or contiguous a sclera of an eye;

and

surgically implanting said device under the Tenon'"'"'s capsule and in contact with or contiguous the sclera of an eye with the hollow reservoir positioned anteriorly on the sclera at a location where a needle can be inserted into the hollow reservoir and with said dispensing outlet being is located posteriorly on the sclera and proximate the location of an internal portion of an eye to be treated by a pharmacological agent.

31. The method for treating an eye of claim 30 wherein said step of surgically implanting includes positioning said dispensing outlet in contact with or contiguous the sclera proximate the macula of an eye.

32. The method for treating an eye of claim 30 wherein said step of surgically implanting includes positioning said dispensing outlet in contact with or contiguous the sclera proximate the optic nerve of an eye.

33. The method for treating an eye of claim 30 wherein said step of surgically implanting includes positioning said dispensing outlet in contact with or contiguous a sclera proximate the optic nerve of an eye.

34. The method for treating an eye of claim 30 wherein said step of surgically implanting includes positioning said dispensing outlet in contact with or contiguous a sclera surrounding the optic nerve of an eye.

35. The method for treating an eye of claim 30 further comprising the step of

injecting through a needle into the hollow reservoir a pharmacologic agent to be used for treating an eye.

36. The method for treating an eye of claim 30 further comprising the step of

injecting through a needle into the hollow reservoir a controlled released drug to be used for treating an eye.

37. The method for treating an eye of claim 36 further comprising the step of

injecting through a needle into the hollow reservoir a controlled released drug configured in the form of micro-spheres having a known dissolution rate for providing a controlled rate of drug delivery through the dispensing outlet for treating an eye.

38. The method for treating an eye of claim 30 further comprising the step of

injecting through a needle into the hollow reservoir a pharmacologic agent comprising anacortate acetate which penetrates through the sclera.

39. The method for treating an eye of claim 36 further comprising the step of

withdrawing through a needle from the hollow reservoir a pharmacologic agent by the steps of alternating injecting sterile air through the needle injection section and withdrawing the pharmacologic agent through the needle.

40. A method for removing a pharmacologic agent from an implant having a needle insert section and a hollow reservoir comprising the steps of:

inserting a needle through the needle insertion section;

injecting a small amount of sterile air through the needle into the hollow reservoir;

allowing bubbles of sterile air to rise to the superior part of the hollow reservoir;

withdrawing an appropriate quantity of pharmacologic agent from the hollow cavity using the needle; and

alternating injecting another small amount of sterile air through the needle into the hollow reservoir and withdrawing through the needle an appropriate quantity of pharmacologic agent until the pharmacologic agent is removed.

41. The method of claim 40 further comprising the step of filling the hollow reservoir with saline or another pharmacologic agent or drug.

42. The method of claim 40 wherein the implant is located on the sclera of an eye and further comprising the step of:

placing the eye in a dependent location.

43. An implantable device to deliver pharmacologic agents through an outer surface tissue of an organ comprising a hollow reservoir;

a delivery tube having a dispensing outlet and wherein said delivery tube is configured in a selected shape to extend from the hollow reservoir to a selected portion of the outer surface tissue of an organ;

said dispensing outlet being configured to be positioned in contact with or contiguous an outer tissue of an organ and proximate to an internal portion of a body to be treated with a pharmacologic agent.

44. An implantable delivery device for delivering a therapeutic agent into a target tissue comprising

an enclosed therapeutic agent container having a dispensing outlet, said container being configured to be implanted in a tunnel or flap of the outer tissue of an organ wherein the dispensing outlet is engaged by and sealed within the tunnel by the outer tissue of an organ enabling administration of a therapeutic agent into the target tissue contiguous to the dispensing outlet.

45. A method for treating an inner portion of an organ within a body having an outer tissue enclosing the organ comprising the steps of:

forming a tunnel or flap in the outer tissue surrounding the organ; and

implanting within said tunnel or flap an implantable delivery device for delivering a therapeutic agent into a target tissue wherein said implantable delivery device includes a therapeutic agent container having a dispensing outlet and wherein said container is configured to be implanted into a tunnel or flap of the outer tissue of an organ and wherein the dispensing outlet is engaged by and sealed within the tunnel by the outer tissue of an organ enabling administration of a therapeutic agent into the target tissue contiguous to the dispensing outlet.

46. The method of claim 45 further comprising a step of:

removablely placing the implantable dispensing device onto the end of an insertion tool.

47. The method of claim 46 further comprising a step of:

inserting the implantable dispensing device located at the end of an insertion tool into the tunnel or flap of the outer tissue and advancing the implantable dispensing device to a desired location within the tunnel or flap of the outer tissue.

48. The method of claim 47 further comprising a step of:

separating the implantable dispensing device from the insertion tool and withdrawing the insertion tool from the tunnel or flap of the outer tissue.